author-photo

J Freiberg-Richter

Dresden University of Technology

35

Papers

980

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Implementing a novel method to estimate the "Burden of Therapy" (BOTh) for patients with metastatic pancreatic cancer treated with gemcitabine plus afatinib vs. gemcitabine in the AIO ACCEPT trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (24)
Randomized phase III study of fluoropyrimidine (FP) plus bevacizumab (BEV) vs. FP plus irinotecan (IRI) and BEV as first-line therapy for metastatic colorectal cancer (mCRC): german AIO KRK0110 (ML22011) - study

2017 Onkologie
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of gemcitabine with erlotinib in rash-positive patients selected according to eligibility for FOLFIRINOX.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
ACCEPT: Afatinib as cancer therapy for exocrine pancreatic tumors–An explorative randomized phase II trial.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
IMAB362 plus zoledronic acid (ZA) and interleukin-2 (IL-2) in patients (pts) with advanced gastroesophageal cancer (GEC): Clinical activity and safety data from the PILOT phase I trial.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Targeting Mycophenolate Mofetil for Graft-Versus-Host Disease Prophylaxis after Allogeneic Blood Stem Cell Transplantation.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Elimination of Imatinib Mesylate and Its Metabolite N-Desmethyl-Imatinib

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Accidental busulfan overdose during conditioning for stem cell transplantation.

2005 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (11)
CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid

2004 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (46)